NDC 0003-2188

ORENCIA

Abatacept

ORENCIA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Abatacept.

Product ID0003-2188_1965849a-8f1d-4015-a434-68f02c6d43c3
NDC0003-2188
Product TypeHuman Prescription Drug
Proprietary NameORENCIA
Generic NameAbatacept
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2011-07-29
Marketing CategoryBLA / BLA
Application NumberBLA125118
Labeler NameE.R. Squibb & Sons, L.L.C.
Substance NameABATACEPT
Active Ingredient Strength125 mg/mL
Pharm ClassesDecreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0003-2188-11

4 SYRINGE, GLASS in 1 CARTON (0003-2188-11) > 1 mL in 1 SYRINGE, GLASS
Marketing Start Date2013-10-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0003-2188-21 [00003218821]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-01

NDC 0003-2188-50 [00003218850]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-07-05

NDC 0003-2188-11 [00003218811]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-10-01

NDC 0003-2188-41 [00003218841]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-29
Marketing End Date2014-09-30

NDC 0003-2188-82 [00003218882]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-29
Marketing End Date2014-09-30

NDC 0003-2188-31 [00003218831]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2011-07-29
Marketing End Date2014-11-30

NDC 0003-2188-91 [00003218891]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-10-01

NDC 0003-2188-51 [00003218851]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-06-07

NDC 0003-2188-90 [00003218890]

ORENCIA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125118
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-07-12

Drug Details

Active Ingredients

IngredientStrength
ABATACEPT125 mg/mL

OpenFDA Data

SPL SET ID:0836c6ac-ee37-5640-2fed-a3185a0b16eb
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 616015
  • 1799228
  • 616018
  • 1799230
  • 1925255
  • 1925254
  • 1925257
  • 1925256
  • 1145929
  • 1145932
  • Pharmacological Class

    • Decreased Cytokine Activity [PE]
    • Selective T Cell Costimulation Modulator [EPC]
    • Recombinant Fusion Proteins [CS]

    NDC Crossover Matching brand name "ORENCIA" or generic name "Abatacept"

    NDCBrand NameGeneric Name
    0003-2187ORENCIAabatacept
    0003-2188ORENCIAabatacept
    0003-2814ORENCIAabatacept
    0003-2818ORENCIAabatacept

    Trademark Results [ORENCIA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ORENCIA
    ORENCIA
    78756090 3184992 Live/Registered
    Bristol-Myers Squibb Company
    2005-11-17
    ORENCIA
    ORENCIA
    78465053 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2004-08-10
    ORENCIA
    ORENCIA
    76213107 2948497 Live/Registered
    BRISTOL-MYERS SQUIBB COMPANY
    2001-02-20

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.